China Orthopedic Instrument Industry Report, Presenting a CAGR of 19.2% and Expected to Grow Faster over the Period 2014-2017

The Report China Orthopedic Instrument Industry Report, 2014-2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -


Albany, NY -- (SBWIRE) -- 06/08/2015 -- Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.

Being optimistic about bright future of China orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China's largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.

View Full Report at

The Chinese orthopedic instrument market now is dominated by Johnson & Johnson, Zimmer, Medtronic, Stryker and other foreign companies, together holding 40%-50% market share. However, local Chinese companies like Shandong Weigao Group Medical Polymer Co. Limited, Shanghai Kinetic Medical Co., Ltd. and United Orthopedic Corporation have made some progress in R&D and production technology in recent years, and grabbed some marker share by virtue of advantages in cost and channel.

Download Sample Copy of this Report at

Shandong Weigao Group Medical Polymer has become the largest local orthopedics company in China with a market share of 4.3%; Shanghai Kinetic Medical is a leader in vertebroplasty interventional operation system, occupying about 50% of the Chinese percutaneous kyphoplasty (PKP) market; United Orthopedic Corporation is a champion in artificial knee/hip joint with 4%-6% market share in China.

Table of Content

1. Overview of Orthopedic Instrument Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development of Global Orthopedic Instrument Industry
2.1 Overview
2.2 Forecast

3. Development of China Orthopedic Instrument Industry
3.1 Overview
3.2 Market Structure
3.3 Import and Export
3.3.1 Import
3.3.2 Export
3.4 Competitive Landscape
3.5 Barriers to Entry
3.5.1 Technology Barrier
3.5.2 Market Access Barrier
3.5.3 Sales Channel Barrier
3.5.4 Talent Barrier
3.6 Sales Model

4. Development Environment of China Orthopedic Instrument Industry
4.1 Policy Environment
4.1.1 Regulatory Policy
4.1.2 Industrial Policy
4.2 Macro Environment
4.3 Upstream and Downstream Industries
4.3.1 Upstream Industry
4.3.2 Downstream Industry

About ( is the most comprehensive collection of market research reports, supporting clients' market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, has built a veritable reputation for fulfilling the most exacting market research needs.

Read our latest articles at

Toll Free: 866-997-4948

Tel: 518-618-1030